Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aphrodine Hydrochloride
2. Aphrodyne
3. Corynanthine
4. Corynanthine Tartrate
5. Hydrochloride, Aphrodine
6. Hydrochloride, Yohimbine
7. Pluriviron
8. Rauhimbine
9. Rauwolscine
10. Tartrate, Corynanthine
11. Yocon
12. Yohimbin Spiegel
13. Yohimbine
14. Yohimbine Houd
15. Yohimex
1. 65-19-0
2. Yohimbine Hcl
3. Antagonil
4. Yohimbe
5. Aphrodine Hydrochloride
6. Yohimbine Monohydrochloride
7. Yohimbine (hydrochloride)
8. Nb2e1yp49f
9. Actibine
10. Mfcd00012674
11. 17-hydroxyyohimban-16-carboxylic Acid Methyl Ester Hydrochloride
12. Yohimbine Chloride
13. Nsc-19509
14. Yohimbin Hcl
15. Chembl537669
16. Methyl (1s,15r,18s,19r,20s)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride
17. Methyl (1s,15r,18s,19r,20s)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate Hydrochloride
18. Smr000058527
19. Yohimbin Hydrochloride [usp]
20. Yohimbin Hydrochloride
21. Sr-01000597896
22. Einecs 200-600-4
23. Nsc 19509
24. Unii-nb2e1yp49f
25. Parkimbine
26. Aphrodyne
27. Gynimbine
28. Menolysin
29. Thybine
30. Tosanpin
31. Yobinol
32. Yohydrol
33. Yocon
34. Ai3-60247
35. Dayto-himbin
36. Sr-01000075297
37. Yohimbine, Hcl
38. Yohimbine Hydrochloride [usp:ban]
39. Prestwick_961
40. Nsc19509
41. Yohimbine-hydrochloride
42. Yohimban-16-carboxylic Acid, 17-hydroxy-, Methyl Ester, Monohydrochloride, (16alpha,17alpha)-
43. Mls001306411
44. Mls001333983
45. Yohimbine Hydrochloride (usp)
46. Dtxsid40891272
47. Hms1569f10
48. Yohimbine Hydrochloride (antagonil)
49. (1r,2s,4ar,13bs,14as)-methyl 2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate Hydrochloride
50. Bcp19708
51. Hy-n0127
52. Nih 9689
53. Tox21_501210
54. Yohimbine Hydrochloride [mi]
55. S2373
56. Akos015951349
57. Ccg-208327
58. Cs-5238
59. Lp01210
60. Yohimbine Hydrochloride [mart.]
61. Yohimbine Hydrochloride [vandf]
62. 17alpha-hydroxy-20-alpha-yohimban-16-beta-carboxylic Acid, Methyl Ester, Hydrochloride
63. Yohimban-16-alpha-carboxylic Acid, 17-alpha-hydroxy-, Methyl Ester, Hydrochloride
64. Yohimban-16alpha-carboxylic Acid, 17alpha-hydroxy-, Methyl Ester, Monohydrochloride
65. Yohimbine Hydrochloride [usp-rs]
66. Yohimbine Hydrochloride [who-dd]
67. Ncgc00094457-01
68. Ncgc00261895-01
69. Ac-22571
70. As-13939
71. Yohimbine Hydrochloride [green Book]
72. Yohimbine Hydrochloride, Analytical Standard
73. Eu-0101210
74. N1704
75. Sw199050-2
76. Y0002
77. Yohimbine Hydrochloride [ep Monograph]
78. D06671
79. Y 3125
80. Yohimbine Hydrochloride [usp Monograph]
81. Yohimbine Hydrochloride, >=98% (tlc), Powder
82. 012y674
83. Q-201938
84. Sr-01000075297-1
85. Sr-01000597896-1
86. Sr-01000597896-4
87. Q15680050
88. 17?-hydroxyyohimban-16?-carboxylic Acid Methyl Ester Hydrochloride
89. Yohimbine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
90. Yohimbine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
91. 17.alpha.-hydroxy-20-.alpha.-yohimban-16-.beta.-carboxylic Acid, Methyl Ester, Hydrochloride
92. Yohimban-16-carboxylic Acid, 17-hydroxy-, Methyl Ester, Hydrochloride (1:1), (16alpha,17alpha)-
Molecular Weight | 390.9 g/mol |
---|---|
Molecular Formula | C21H27ClN2O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 390.1710204 g/mol |
Monoisotopic Mass | 390.1710204 g/mol |
Topological Polar Surface Area | 65.6 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 555 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Adrenergic alpha-2 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?